SourcingAI
Try for free
Powered by Made-in-China.com
High Quality GMP Certified Fortified Procaine Penicillin for Injection
US$0.17
100,000 vial

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

for Injection

Model NO.

1.2mega, 2.0mega, 4.0mega

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Transport Package

1vials/Box, 25vials/Box

Trademark

Reyoung

Origin

China Reyoung

HS Code

30049090

Production Capacity

50million Vials/Year

Key features

Broad Spectrum Antibacterial: Effective against gram-positive bacteria and specific gram-negative cocci like Neisseria.
Prolonged Depot Action: Forms a depot at injection site for slow release, offering prolonged activity vs benzylpenicillin.
Massive Production Capacity: Annual capacity of 2.5 billion vials powder for injection and 4 billion tablets.
Global Export Experience: Exported to over 70 countries with GMP passed inspections in Colombia, Peru, etc.
Customizable OEM/ODM: Offers OEM and ODM services with 370 R&D engineers for tailored pharmaceutical solutions.
Reputable Manufacturer: Established in 1966, a leading Chinese manufacturer with famous 'REYOUNG' trademark.
Versatile Pharmaceutical Range: Produces 10 categories including tablets, capsules, granules, and sterile active ingredients.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.
Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.
CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.
R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.
Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.
Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:Is this product suitable for children and the elderly?
A:
Yes, the product is suitable for adults, children, and the elderly as indicated in its attributes.
Q:What certifications does the manufacturer hold?
A:
Reyoung Pharma is certified with GMP, ISO9001, ISO14001, and OHS18001, and has passed GMP inspections in multiple countries including Colombia, Peru, and Pakistan.
Q:What are the payment terms for this product?
A:
The accepted terms of payment are LC (Letter of Credit), T/T (Telegraphic Transfer), and D/P (Documents against Payment).
Q:What is the lead time for production?
A:
The average lead time is 1-3 months for both peak season and off-season periods.
Q:Does the manufacturer offer OEM or ODM services?
A:
Yes, the manufacturer offers both OEM and ODM services, supported by a team of 370 R&D engineers.

Send Inquiry

*To:Reyoung Pharmaceutical Co., Ltd.Reyoung Pharmaceutical Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

High Quality Food Grade Citric Acid Monohydrate
Made-in-China.com
Premium Food Grade Citric Acid Monohydrate for Sale
Made-in-China.com